Latest data from June 17, 2022
Number of Health Center respondents = 32 (82% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 3,523 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 58.70% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 620 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 59.50% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 39.88% | 38.87% |
White, Hispanic/Latino Patients | 12.32% | 10.81% |
Black/African American, Non-Hispanic/Latino Patients | 30.60% | 34.03% |
Black/African American, Hispanic/Latino Patients | 0.68% | 0.16% |
Asian Patients3 | 0.91% | 0.00% |
American Indian/Alaska Native Patients3 | 2.95% | 5.16% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.43% | 0.16% |
Patients with More Than One Race3 | 2.72% | 2.58% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.07% | 4.19% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.22% | 1.61% |
Unreported/Refused to Report Race and Ethnicity | 2.21% | 2.42% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 347 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 69.82% |
COVID-19 Immunization Series Completed | 161 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 79.72% |
COVID-19 Immunization Series Additional | 1,858 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 76.77% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 29.39% | 18.01% | 22.07% |
White, Hispanic/Latino Patients | 7.49% | 31.68% | 9.26% |
Black/African American, Non-Hispanic/Latino Patients | 54.76% | 22.98% | 28.79% |
Black/African American, Hispanic/Latino Patients | 0.29% | 1.24% | 0.32% |
Asian Patients3 | 0.86% | 0.62% | 0.54% |
American Indian/Alaska Native Patients3 | 0.58% | 0.62% | 8.88% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.62% | 0.11% |
Patients with More Than One Race3 | 0.86% | 3.11% | 1.18% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.17% | 9.94% | 23.84% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.44% | 2.48% | 0.86% |
Unreported/Refused to Report Race and Ethnicity | 1.15% | 8.70% | 4.14% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 21.88% |
1 to 24 Hours | 9.38% |
More Than 24 Hours | 68.75% |
N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 6.25% |
Staffing to administer the vaccine | 37.50% |
Vaccine confidence | 9.38% |
Vaccine storage capacity | 0.00% |
Vaccine supply | 6.25% |
Other | 0.00% |
None | 56.25% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 46.88% |
Average Percent of Health Center Visits Conducted Virtually | 11.41% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 25.00% |
Number of Mobile Van Sites | 7 |
Number of Pop-up Clinics | 5 |
Number of School-Based Vaccination Sites | 0 |
Number of Family Vaccination Clinics | 8 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 0.00% |
Refer patients to another organization that provides monoclonal antibody therapies | 71.88% |
None | 28.12% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 3.12% |
Patient awareness/education | 3.12% |
Staffing capacity | 15.62% |
Therapy administration/onsite logistics | 12.50% |
Other | 3.12% |
None | 71.88% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 22 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 3,621 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 54.55% |
Provided to General Public Who Came to the Health Center | 54.55% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 18.18% |
Provided at Other Community Events | 22.73% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 18.18% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 4.55% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 16 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 2,781 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 75.00% |
Provided to General Public Who Came to the Health Center | 62.50% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 18.75% |
Provided at Other Community Events | 25.00% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 6.25% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 6.25% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 6 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 34.21% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 65.79% |
White, Hispanic/Latino Patients | 2.63% |
Black/African American, Non-Hispanic/Latino Patients | 18.42% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 0.00% |
American Indian/Alaska Native Patients3 | 7.89% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
Patients with More Than One Race3 | 2.63% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.63% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Unreported/Refused to Report Race and Ethnicity | 0.00% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 0.00% |
Patients Experiencing Homelessness | 0.00% |
Patients Who Are Residents of Public Housing | 2.63% |
Patients with Limited English Proficiency | 2.63% |
Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.